Fusion Antibodies plc (AIM: FAB)
Health Care · Life Sciences Tools & Services · GB
£0.11
+7.14% today · -30.0% 1Y
Fusion Antibodies plc (AIM: FAB) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $17.91M.
Over the last twelve months the share price has lost 30.0%, trading between 0.10 and 0.21.
Tweenvest scores Fusion Antibodies plc across four factors: quality 23/100, value 49/100, growth 63/100. Its strongest factor is growth.
FAB price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $17.91M
- Revenue (TTM)
- $2.15M
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.22
- 52-week high
- £0.21
- 52-week low
- £0.10
- Avg volume (3M)
- —
- Shares outstanding
- 125.16M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.26B | $628.15 | -0.09% |
| Danaher CorporationNYSE: DHR | $151.82B | $215.97 | +0.40% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $71.35B | CN¥161.00 | +3.31% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.65B | CHF593.80 | +1.02% |
| Agilent Technologies, Inc.NYSE: A | $43.71B | $154.77 | +0.87% |
| IQVIA Holdings Inc.NYSE: IQV | $42.70B | $259.42 | -0.32% |
| Waters CorporationNYSE: WAT | $40.72B | $414.44 | +0.90% |
Figures last refreshed Aug 18, 2026.